Correlation Between SAB Biotherapeutics and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Processa Pharmaceuticals, you can compare the effects of market volatilities on SAB Biotherapeutics and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Processa Pharmaceuticals.
Diversification Opportunities for SAB Biotherapeutics and Processa Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between SAB and Processa is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Processa Pharmaceuticals
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 0.76 times more return on investment than Processa Pharmaceuticals. However, SAB Biotherapeutics is 1.31 times less risky than Processa Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 643.00 in SAB Biotherapeutics on November 5, 2024 and sell it today you would lose (424.00) from holding SAB Biotherapeutics or give up 65.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Processa Pharmaceuticals
Performance |
| Timeline |
| SAB Biotherapeutics |
| Processa Pharmaceuticals |
SAB Biotherapeutics and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Processa Pharmaceuticals
The main advantage of trading using opposite SAB Biotherapeutics and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |